MassMutual Private Wealth & Trust’s Fennec Pharmaceuticals FENC Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$522	Sell	49 -308	-86%	-$3.39K	﹤0.01%	2206
2026 Q2	$3.84K	Hold	357	–	–	﹤0.01%	1782
2026 Q1	$2.2K	Hold	357	–	–	﹤0.01%	1954
2025 Q4	$2.75K	Hold	357	–	–	﹤0.01%	1904
2025 Q3	$3.34K	Hold	357	–	–	﹤0.01%	1827
2025 Q2	$2.96K	Sell	357 -625	-64%	-$4.28K	﹤0.01%	1830
2025 Q1	$5.98K	Hold	982	–	–	﹤0.01%	1517
2024 Q4	$6.21K	Buy	982 +924	+1,593%	+$4.73K	﹤0.01%	1447
2024 Q3	$290	Buy	+58	New	+$336	﹤0.01%	2055

Other funds holding FENC

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return

Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Sierra Summit Advisors Incline Village, Nevada $852M AUM 73.11% 1-Year Est. Return

Legato Capital Management San Francisco, California $1.11B AUM 60.78% 1-Year Est. Return

Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

MassMutual Private Wealth & Trust's FENC Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its Fennec Pharmaceuticals (FENC) stake by 86% in Q3 2026, selling an estimated $3.39K and leaving 49 shares worth $522. The position accounts for ﹤0.01% of the portfolio, ranked #2206.

MassMutual Private Wealth & Trust first reported a position in FENC in Q3 2024 and has held it in 9 quarters since. The position peaked at $6.21K in Q4 2024. 48 funds tracked by Wall St. Rank hold FENC as of Q3 2026.

MassMutual Private Wealth & Trust held 49 shares of Fennec Pharmaceuticals worth $522 as of Q3 2026.
MassMutual Private Wealth & Trust sold 308 Fennec Pharmaceuticals shares in Q3 2026, an estimated $3.39K.
Fennec Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #2206 holding.
MassMutual Private Wealth & Trust first reported a position in Fennec Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
MassMutual Private Wealth & Trust's Fennec Pharmaceuticals position peaked at $6.21K in Q4 2024.
48 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.